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ABSTRACT
Objectives. To investigate the ability 
of ultrasonography (US) to detect syn-
ovitis in metatarsophalangeal joints 
(MTP) in patients with suspicion of 
early arthritis, and to discriminate be-
tween diagnoses.
Methods. Patients referred to early ar-
thritis clinics for differential diagnosis 
were enrolled, and clinical and labora-
tory measures were recorded. Ultra-
sonography of MTPs was performed 
searching for synovial hypertrophy 
(SH), joint effusion (JE) and power 
Doppler (PD), graded from 0 to 3 on a 
semi-quantitative scale.
Patients were classified according to 
definite classification criteria, or as 
undifferentiated arthritis or non-in-
flammatory pathology. US findings 
were compared across different diag-
noses and diagnostic accuracy was 
calculated taking clinical diagnosis as 
reference.
Results. Out of 427 patients (71% 
rheumatoid arthritis (RA), 20% undif-
ferentiated arthritis (UA), 15% spon-
dyloarthritides (SpA), 13% non-inflam-
matory), 307 (71.9%) showed SH, 120 
(25.5%) JE, 77 (18.0%) PD. RA patients 
had median JE, SH and PD scores sig-
nificantly higher than non-inflamma-
tory and other diseases. Patient with 
UA and SpA had higher scores of SH 
and JE compared to non-inflammatory, 
no significant differences were present 
among different diagnosis. In RA, SH 
and JE were more frequently detected 
in the second MTP, and PD in the fifth. 
Crystal-related arthritis showed a ten-
dency towards a more frequent involve-
ment of the first MTP. The diagnostic 
accuracy of single US measures was 
moderate, but the detection of a PD of 
2 or more provided a high specificity 
for the diagnosis of RA.
Conclusions. US can be used as ad-
ditional information in patients evalu-
ated in an early arthritis setting. High 
scores of JE, SH and PD, together with 
the pattern of involvement are sugges-
tive of RA.
Introduction
Despite the introduction in the last 
decades of many innovative therapeu-
tic agents and strategies in the man-
agement of rheumatoid arthritis (RA), 
early diagnosis and intervention are 
still crucial (1, 2). In this context, it 
is important to define features that are 
present at the onset in early arthritis 
and that could be helpful in order to de-
fine diagnosis and improve therapeutic 
management (3. 4).
Many clinical, demographical and lab-
oratory parameters have been investi-
gated for this purpose (3-6). In particu-
lar, the extent and sites of joint involve-
ment are regarded as additional diag-
nostic and prognostic factors (7-10). 
For instance, the early involvement of 
metatarsophalangeal joints (MTPs) has 
been believed to be useful in detecting 
persistent and erosive arthritis at the 
onset (11).
The clinical involvement of MTPs oc-
curs frequently in polyarticular onset 
inflammatory arthritis (up to 50.3% of 
patients) (12), and the fifth MTP has 
been shown in imaging studies to be an 
early site of bone erosions (13). Never-
theless, the reliability of clinical evalu-
ation of these joints has been largely 
discussed. In fact, imaging studies 
comparing clinical evaluation to MRI 
as reference standard for the detection 
of synovitis, have shown poor sensitiv-
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ity; conversely, ultrasonography (US) 
has proven to be more accurate (14).
A few studies have specifically ad-
dressed the potential role of US in the 
evaluation of MTPs. In particular, US 
has been demonstrated to be more sen-
sitive than conventional radiography 
in detecting bone erosions in the fifth 
MTP (15, 16). A very recent study has 
investigated the potential role of an 
extensive US joint count, including 
MTPs, to predict the subsequent devel-
opment of RA in a cohort of very early 
inflammatory arthritides (symptom 
duration <3 months). MTP synovitis, 
documented by US, was frequently 
clinically undetected and US involve-
ment of MTPs was significantly more 
frequent in patients that developed RA 
subsequently. The same trend, even if 
less pronounced, was evident also for 
patients with longer symptom duration 
(more than 3 months but less than 1 
year) (17).
In this work we systematically applied 
US to identify joint inflammation at 
the MTP joints in patients with early 
arthritis in order to investigate its di-
agnostic properties on the discrimina-
tion between different diseases. For 
this purpose we included a sample of 
patients with early arthritis and we 
cross-sectionally analysed the baseline 
association between US MTP involve-
ment and clinical diagnosis.
Methods
Setting and participants
Patients with clinical suspicion of in-
flammatory polyarthritis were referred 
to the early arthritis clinics for differen-
tial diagnosis. The data collected dur-
ing the baseline evaluation were used 
for cross-sectional analyses. All sub-
jects gave written consent.
Patient assessment
The clinical assessment included: ten-
der and swollen joint count (TJC, SJC) 
on 28 joints, tender and joint count at 
MTPs, visual analogue scale (VAS) for 
pain, examinator’s global assessment 
(EGA) and global health assessment 
(GH). Laboratory tests included rheu-
matoid factor (RF), anti-citrullinated 
peptide antibodies (ACPA), antinucle-
ar antibodies (ANA), erythrocyte sedi-
mentation rate (ESR) and C-reactive 
protein (CRP). Functional disability 
was assessed by the Italian version of 
the HAQ (18).
At baseline patients were classified 
with a clinical diagnosis based on es-
tablished classification criteria (19-22).
Patient with clinical evidence of in-
flammatory arthritis of at least one 
joint who did not fulfil any classifica-
tion criteria were defined as undiffer-
entiated arthritis. Patients without any 
clinical sing of joint inflammation were 
labelled as “non-inflammatory”.
Musculoskeletal ultrasonography 
US assessment was performed in each 
centre by experienced operators, using 
a Logiq 9 (General Electrics Medical 
Systems, Milwaukee, WI) with multi-
frequency linear probes (8-14 MHz) 
according to the European League 
Against Rheumatism (EULAR) guide-
lines (23). Inter-reader reliability has 
been evaluated in a previous study 
(24). To avoid “review biases” the ul-
trasonographer was unaware of the 
clinical data at the exam session.
The scanning protocol of MTP joints 
was performed as already detailed else-
where (25).
The presence of joint effusion (JE) and 
synovial hypertrophy (SH) was identi-
fied in each joint as abnormal anechoic/
hypoechoic intra-articular material ac-
cording to the OMERACT definitions 
(26). JE and SH were subjectively grad-
ed from 0 to 3 (0 = normal; 1 = mild; 2 
= moderate; 3 = marked) (25, 27). Syn-
ovial power Doppler (PD) was assessed 
by selecting a region of interest that 
included the bony margins, joint space 
and a variable view of surrounding tis-
sues (depending on the joint size). PD 
calibrations were adjusted at the lowest 
permissible pulse repetition frequency 
to maximise sensitivity and were taken 
as constant in different patients. Dop-
pler frequency was set for the study 
of small joints and superficial tissues. 
Colour gain was set just below the level 
that causes the appearance of noise ar-
tefacts. Flow was demonstrated in two 
perpendicular planes and confirmed 
by pulsed wave Doppler spectrum to 
exclude artefacts. The PD signal was 
subjectively graded on a semi-quantita-
tive scale from 0 to 3 (0 = absence or 
minimal flow; 1 = mild: single vessel 
signal; 2 = moderate: confluent vessels; 
3 = marked: vessel signals in >50% of 
the joint area) on the image with the 
maximal enhancement on PD (23, 28, 
29). A joint was considered involved 
when at least score 1 JE, SH and/or PD 
signal were detected by US. 
Statistical methods
Summary statistics of mean and stand-
ard deviation (SD) or median and inter-
quartile range (IQR) were presented for 
continuous variables when appropriate. 
Categorical variables were summarised 
using both absolute and relative fre-
quencies. 
Only patients with complete clinical 
and US data at baseline were included 
in analysis.
To test equality of population medians 
among groups, Kruskal-Wallis one-way 
analysis of variance by ranks was ap-
plied. Differences between specific di-
agnoses were analysed using the Mann-
Whitney test. Due to multiple compari-
sons, statistical significance was set at 
0.01 level.
Comparison between frequencies across 
different joints were tested using the 
two-sample test of proportion (z-test).
Diagnostic accuracy measures (sensi-
tivity, specificity, likelihood ratios, area 
under the ROC curve) were calculated 
using clinical diagnosis as reference 
and US measures as index tests. 
All analyses were done using Stata 
version 11 (StataCorp, College Station, 
TX).
Results
Participants
We cross-sectionally analysed a total of 
427 subjects. Their main clinical char-
acteristics are summarised in Table I. 
Overall, the study sample included 
patients with median (IQR) age of 57 
(46-69) years, higher prevalence of 
female gender (75.8%), median (IQR) 
symptoms duration of 3.86 (2.41–6.98) 
months, and average moderate func-
tional disability (median [IQR] HAQ 
1.0 [0.625–1.625]).
In the examined study sample, the 
subjects were clinically diagnosed as 
follows: 178 (41.7%) RA, 86 (20.1%) 
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UA, 63 (15.8%) SpA, 21 (4.9%) CTD, 
20 (4.7%) CrA and 59 (13.8%) with-
out clinically detectable inflammatory 
arthropathy. 
US involvement of feet
Overall, 307 (71.9%) subjects showed 
at least JE score 1, while only 120 
(25.5%) and 77 (18.0%) showed at 
least score 1 in SH and PD scores, re-
spectively.
Descriptive measures of different US 
scores stratified by clinical diagnosis 
are reported in Table II. 
All the US scores (JE, SH and PD) 
significantly differed across different 
diagnostic categories (Kruskal-Wallis 
p<0.001).
Analysing differences among different 
diagnoses, patients with RA showed 
median JE, SH and PD scores signifi-
cantly higher than patients with both 
other inflammatory and non-inflamma-
tory arthropathies. (Mann-Whitney all 
p<0.01)
Within inflammatory arthritides other 
than RA, no significant differences 
were observed in JE, SH and PD scores 
(Kruskal-Wallis p=0.91, 0.41 and 0.47, 
respectively).
Comparing single diagnoses to non-
inflammatory arthropathy, only UA 
and SpA showed a significant differ-
ence in median JE score (p<0.001 and 
p=0.001, respectively), while in CTD 
and CrA median JE scores was only 
weakly increased (p=0.02 and p=0.05). 
Median SH score was significantly 
higher only for UA and SpA (p<0.001 
and p=0.001), while median PD score 
was weakly increased in SpA and CTD 
(p=0.03 and p=0.02).
Pattern of joint involvement 
Pattern and frequency of involvement 
at single joint level are depicted in Fig-
ure 1. 
In RA, JE, SH or grey scale synovitis 
(GS) at single joint level were more 
frequent in 2nd to 4th MTP than in 1st 
MTP and 5th MTP (z-test p=0.0001 1st 
vs. 2nd and p=0.01 4th vs. 5th).
In subjects with other diagnoses, a 
prevalence of GS involvement showed 
a similar pattern, though with less sig-
nificant differences in UA and SpA.
Crystal-related arthropathies showed a 
tendency toward more frequent involve-
ment of the 1st MTP. Non-inflammatory 
arthropathy showed a decreasing me-
dio-lateral trend of GS involvement.
In RA, the PD pattern showed a slight- 
ly more prevalent involvement of the 
5th MTP joint bilaterally (p=0.01 and 
p=0.005 for 1st vs. 5th left and right 
MTP, respectively).
The presence of PD synovitis was min-
imally prevalent in conditions other 
than RA and did not show any particu-
lar pattern. 
 
Diagnostic accuracy
Due to the association of both GS and 
PD US variable to the clinical diagno-
sis of RA we explored the diagnostic 
properties of US in discriminating be-
tween RA and other diagnoses in early 
arthritis setting.
Overall diagnostic accuracy of single 
US measures was moderate. The AUC 
was 0.75 (0.71, 0.80) for the JE score, 
0.64 (0.60, 0.68) for the SH score, and 
0.63 (95%CI 0.60, 0.67) for the PD 
score.
Analysing the different cut-offs, at least 
1 point of JE score associated with a 
negative LR of 0.31, while more than 
2 points of PD score associated with a 
positive LR of 46.16.
Discussion
With early referral and treatment becom-
ing a central issue in the management 
of inflammatory arthritis, the focus is 
now on features that might distinguish 
between different types of arthritis at 
the onset, in order to optimise manage-
ment and prevent long-term detrimental 
outcomes.
In this context, the discriminative abil-
ity of extensive US joint counts to de-
tect RA has been evaluated (17), and 
in some cases added to diagnostic al-
gorithms including clinical and labora-
tory parameters (31, 32). Site-specific 
US evaluations have not been specially 
considered yet.
Table I. Study sample clinical characteristics.
Characteristic All subjects
Number 427
Age (years), median (IQR) 57 (46-69)
Female, n. (%) 323 (75.8)
Disease duration (months), median (IQR) 3.86 (2.41–6.98)
RF (+ve), n. (%) 97/423 (22.9)
ACPA (+ve), n. (%) 66/416 (15.8)
ANA, n. (%) 151/420 (35.9)
VAS pain (mm), median (IQR) 51 (40–75)
VAS physician (mm), median (IQR) 36 (20–50)
VAS GH (mm), median (IQR) 55 (50–75)
SJC28, median (IQR) 6 (3–10)
TJC28, median (IQR) 6 (2–12)
Swollen MTF, median (IQR) 2 (0–4)
Tender MTF, median (IQR) 1 (0–4)
ESR (mm/h), median (IQR) 20 (12–6)
CRP (mg/dl), median (IQR) 0.47 (0.30–1.51)
HAQ, median (IQR) 1 (0.625–1.625)
Table II. Mean ultrasonographic scores according to clinical diagnosis.
Diagnosis n. (%) JE score SH score PD score
  mean (SD) mean (SD) mean (SD)
RA 178 (41.7) 6.5 (5.5) 2.1 (3.6) 1.4 (2.9)
UA 86 (20.1) 2.7 (3.2) 0.5 (1.7) 0.1 (0.4)
SpA 63 (15.8) 2.8 (3.2) 0.7 (1.9) 0.3 (1.4)
CTD 21 (4.9) 3.0 (3.8) 0.8 (2.3) 0.2 (0.5)
CrA 20 (4.7) 2.0 (2.1) 0. (0.3) 0.05 (0.2)
N-I 59 (13.8) 1.1 (1.6) 0.3 (1.1) 0.03 (0.3)
Total 427 (100) 4.1 (4.7) 1.2 (2.7) 0.7 (2.1)
JE: joint effusion; SH: synovial hypertrophy; PD: power Doppler; RA: rheumatoid arthritis; UA: undif-
ferentiated arthritis; SpA: spondyloarthropaties; CTD: connective tissue diseases; CrA: crystal-associ-
ated arthritis; N-I: non-inflammatory arthropathy.
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To evaluate the usefulness for diag-
nostic purposes of targeted US of the 
MTPs in early arthritis, we studied a 
large sample of patients referred for 
suspicion of new onset arthritis.
The distribution of different diagno-
sis in our population demonstrated a 
higher frequency of RA and lower fre-
quency of CrA, compared to similar 
cohorts, while the distribution of other 
diseases was similar (33).
So far, only a few studies have specifi-
cally dealt with US findings in MTPs. 
The main interest was focused on the 
detection of bone erosions in specific 
sites, such as the fifth MTP (15). Sz-
kludarek and colleagues investigated 
the ability of US to detect synovitis, 
defined as synovial thickening, in the 
MTPs. In this population of treated RA 
patients, the US involvement of MTPs 
occurred in about half of patients, 
with the second and the fifth MTP be-
ing more frequently involved, which 
is consistent with our findings (14). A 
very recent study describing US fea-
tures of feet in patients with RA, de-
tected up to 62% of synovitis (JE with 
SH) in the MTPs (34). Overall, the fre-
quency of US MTP involvement seems 
to be comparable to our population.
Despite these few studies, which were 
mainly based on patients with definite 
diagnosis of RA, there is still a lack of 
information on the diagnostic proper-
ties of US involvement of MTPs at 
early stages.
In our study, US in MTPs showed a 
possible role in discriminating between 
inflammatory and non-inflammatory 
arthropathies, and this might give addi-
tional information together with clini-
cal and laboratory parameters. This 
potential diagnostic role was more 
evident for RA, UA and SpA, while not 
significant for other diseases, and this 
might be due to the small sample size 
in some categories of patients.
In particular, RA was associated with 
the highest scores of JE, SH and PD, 
with a significant difference compared 
to non-inflammatory conditions and 
other diseases. This is in line with pre-
vious findings, showing a significantly 
higher MTP involvement in patients 
who would later develop RA (17).
Conversely, in our analysis we did not 
find significant differences in median 
US scores among UA, SpA, CTA and 
CrA. As groups were unbalanced, due 
to the different prevalence of the disease 
in the study sample, the analysis is un-
derpowered. True differences between 
these diagnoses could have been missed 
in this context. Similar considerations 
should be taken into account when in-
terpreting post-hoc analyses comparing 
single diagnoses with non-inflamma-
tory patients. Studies considering larger 
samples are needed for this purpose.
As previously reported, in RA the MTP 
joints that seem more frequently affect-
ed by SH are the second and the fifth 
MTP (14). This was partially confirmed 
in our population, in which the second 
MTP showed more JE and SH, while 
the fifth MTPs had more frequently 
positive PD, and this is coherent with 
the high rate of bone erosions reported 
at this site (15), as also confirmed by 
findings on our population (data not 
shown).
In crystal-related arthritis, the first MTP 
is considered a frequently involved area 
(35). This is confirmed in our cohort, in 
which both GS and PD abnormalities 
showed a tendency towards a more fre-
quent localisation at this site.
As expected the diagnostic accuracy of 
a single measure (US examination of 
foot) in discriminating RA patients from 
other diagnoses was only moderate. Pre-
vious studies have already used a more 
extensive US examination (31, 32) to-
gether with clinical and serological find-
ings in predictive models in UA.
Nevertheless, the detection of 1 point 
JE score at foot level indicates a nega-
tive LR of 0.31, that indicates a moder-
ate sensitivity in detecting RA patients. 
On the other hand, the detection of a 
PD score of 2 or more in MTPs pro-
vided a high positive LR of 46.16, in-
dicating the ability to identify RA with 
high specificity.
The study carries some limitations as 
well. The cross sectional design does 
Fig. 1. Pattern of metatarsophalangeal (MTP) involvement identified by ultrasonography. Single joint 
involvements are presented according to different clinical diagnoses. In panel A, US involvement is 
defined as presence of at least grade 1 JE or SH (grey scale); in panel B US involvement is defined as 
presence of at least grade 1 PD signal. Single joints are reported in the x axis according to their “radio-
logical” order from the fifth right MTP to the fifth left MTP. 
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not allow the evaluation of the pre-
dictive validity of US features against 
long term diagnosis. Furthermore, the 
application of a univariate analysis 
might not take into account possible 
confounders.
There might be a misclassification of 
the involvement in certain joints. For 
instance, the detection of PD in the fifth 
MTPs might have been overestimated, 
based on finding in the other MTPs, due 
to the known early involvement of this 
area. Conversely, considering that small 
effusions are detectable also in healthy 
individuals, findings in the first MTP 
might have been underestimated.
Overall, the use of MTP US provides ad-
ditional useful information to integrate 
clinical history, physical examination 
and laboratory findings, in particular to 
discriminate between inflammatory and 
non-inflammatory pathology. US can 
individuate the subgroup of patients 
with more severe prognosis: in fact, the 
detection of high scores of GS and PD 
is highly suggestive for the diagnosis of 
RA, and further information can be ob-
tained evaluating frequently involved 
sites, such as the fifth MTP. For these 
reasons, the application of foot US can 
be considered in patients presenting 
with suspicion of new onset arthritis.
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